MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Seer, Inc.

< Previous 1 2 3 Next >
News headline image
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Files ITC Complaint Against Nanomics
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Files Patent Infringement Lawsuit Against Nanomics
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer to Report First Quarter 2026 Financial Results on May 13, 2026
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer to Participate in the TD Cowen 46th Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
News headline image
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
From Seer, Inc.
Via GlobeNewswire
Tickers SEER
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story